{"product_id":"krka-dehispot-30-mg-7-5-mg-0-35ml-for-cats-0-5-2-5kg-n1","title":"KRKA Dehispot 30 mg \/ 7,5 mg 0.35ml for Cats 0.5-2.5kg N1","description":"\u003ch1\u003ePACKAGE LEAFLET\u003c\/h1\u003e\n\u003ch2\u003e1. Name of the veterinary medicinal product\u003c\/h2\u003e\n\u003cp\u003eDehispot 30 mg\/7.5 mg spot-on solution for small cats\u003c\/p\u003e\n\u003cp\u003eDehispot 60 mg\/15 mg spot-on solution for medium-sized cats\u003c\/p\u003e\n\u003cp\u003eDehispot 96 mg\/24 mg spot-on solution for large cats\u003c\/p\u003e\n\u003ch2\u003e2. Composition\u003c\/h2\u003e\n\u003cp\u003eEach unit dose (pipette) contains:\u003c\/p\u003e\n\u003ch3\u003eActive substances\u003c\/h3\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eDehispot spot-on solution\u003c\/th\u003e\n\u003cth align=\"right\"\u003ePipette volume (ml)\u003c\/th\u003e\n\u003cth align=\"right\"\u003ePraziquantel\u003c\/th\u003e\n\u003cth align=\"right\"\u003eEmodepside\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSmall cats (≥ 0.5–2.5 kg)\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e0.35\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e30 mg\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e7.5 mg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedium-sized cats (\u0026gt; 2.5–5 kg)\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e0.70\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e60 mg\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e15 mg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLarge cats (\u0026gt; 5–8 kg)\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e1.12\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e96 mg\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e24 mg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch3\u003eExcipient\u003c\/h3\u003e\n\u003cp\u003eButylhydroxyanisole (E320): 5.4 mg\/ml.\u003c\/p\u003e\n\u003cp\u003eClear, colourless to yellow or brown solution.\u003c\/p\u003e\n\u003ch2\u003e3. Target species\u003c\/h2\u003e\n\u003cp\u003eCats.\u003c\/p\u003e\n\u003ch2\u003e4. Indications for use\u003c\/h2\u003e\n\u003cp\u003eFor use in cats with mixed parasitic infestations or at risk of infestation with roundworms and tapeworms against which each active substance in the combination is effective.\u003c\/p\u003e\n\u003cp\u003eThis veterinary medicinal product is indicated only when treatment against roundworms and tapeworms is required at the same time.\u003c\/p\u003e\n\u003ch3\u003eRoundworms (nematodes)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cem\u003eToxocara cati\u003c\/em\u003e — mature adults, immature adults, L3 and L4 larvae.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cem\u003eToxocara cati\u003c\/em\u003e — L3 larvae; for the treatment of queens during late pregnancy to prevent transmission of the infestation to their offspring through milk.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cem\u003eToxascaris leonina\u003c\/em\u003e — mature adults, immature adults and L4 larvae.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cem\u003eAncylostoma tubaeforme\u003c\/em\u003e — mature adults, immature adults and L4 larvae.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTapeworms (cestodes)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cem\u003eDipylidium caninum\u003c\/em\u003e — mature and immature adults.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cem\u003eTaenia taeniaeformis\u003c\/em\u003e — adults.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cem\u003eEchinococcus multilocularis\u003c\/em\u003e — adults.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e5. Contraindications\u003c\/h2\u003e\n\u003cp\u003eDo not use in kittens younger than eight weeks of age or weighing less than:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e0.5 kg for the veterinary medicinal product intended for small cats;\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e2.5 kg for the veterinary medicinal product intended for medium-sized cats;\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e5 kg for the veterinary medicinal product intended for large cats.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDo not use in cases of hypersensitivity to the active substances or to any of the excipients.\u003c\/p\u003e\n\u003ch2\u003e6. Special warnings\u003c\/h2\u003e\n\u003ch3\u003eSpecial warnings\u003c\/h3\u003e\n\u003cp\u003eUnnecessary use of antiparasitic products or use that does not comply with the instructions in the Summary of Product Characteristics may increase the selection pressure for resistance and reduce treatment efficacy.\u003c\/p\u003e\n\u003cp\u003eThe decision to use this veterinary medicinal product should be based on confirmation of the parasite species and parasite burden in each individual animal, or on the risk of infestation based on its epidemiological characteristics.\u003c\/p\u003e\n\u003cp\u003eWhere there is no risk of co-infestation, a narrow-spectrum veterinary medicinal product should be used.\u003c\/p\u003e\n\u003cp\u003eConsideration should be given to the possibility that other animals in the same household may be a source of repeated nematode and\/or tapeworm infestation. Where necessary, their infestations should be treated with an appropriate veterinary medicinal product.\u003c\/p\u003e\n\u003cp\u003eWhere an infestation with the tapeworm \u003cem\u003eDipylidium caninum\u003c\/em\u003e has been confirmed, simultaneous treatment against intermediate hosts, such as fleas and lice, should be discussed with a veterinarian to prevent reinfestation.\u003c\/p\u003e\n\u003cp\u003eFrequent and repeated use of anthelmintics from this group may result in parasite resistance to anthelmintics of any group.\u003c\/p\u003e\n\u003cp\u003eResistance of \u003cem\u003eDipylidium caninum\u003c\/em\u003e to praziquantel has been reported in dogs.\u003c\/p\u003e\n\u003cp\u003eWhen using this veterinary medicinal product, local information concerning the susceptibility of the target parasites should be taken into account, where available.\u003c\/p\u003e\n\u003cp\u003eFurther investigation using an appropriate diagnostic method is recommended in cases of suspected resistance.\u003c\/p\u003e\n\u003cp\u003eConfirmed resistance should be reported to the marketing authorisation holder or to the competent authorities.\u003c\/p\u003e\n\u003cp\u003eShampooing or immersing the animal in water immediately after treatment may reduce the effectiveness of this veterinary medicinal product. Treated animals should therefore not be washed until the solution has dried.\u003c\/p\u003e\n\u003ch3\u003eSpecial precautions for safe use in the target species\u003c\/h3\u003e\n\u003cp\u003eApply only to intact, undamaged skin.\u003c\/p\u003e\n\u003cp\u003eDo not administer orally or parenterally.\u003c\/p\u003e\n\u003cp\u003eAfter treatment, do not allow the treated cat or other cats to lick the application site while it is still wet.\u003c\/p\u003e\n\u003cp\u003eThere is insufficient experience with the use of this veterinary medicinal product in sick or debilitated animals. It should therefore only be used in such animals following an assessment of the potential benefit-risk balance by the treating veterinarian.\u003c\/p\u003e\n\u003ch3\u003eSpecial precautions to be taken by the person administering the veterinary medicinal product to animals\u003c\/h3\u003e\n\u003cp\u003eThis veterinary medicinal product may cause irritation to the skin and eyes.\u003c\/p\u003e\n\u003cp\u003eIn the event of accidental contact with the skin, wash immediately with soap and water.\u003c\/p\u003e\n\u003cp\u003eIf the veterinary medicinal product accidentally comes into contact with the eyes, rinse them with plenty of water.\u003c\/p\u003e\n\u003cp\u003eIf skin or eye symptoms persist after rinsing, or in the event of accidental ingestion, seek medical advice immediately and show the package leaflet or label to the physician.\u003c\/p\u003e\n\u003cp\u003eAvoid direct contact with the treated area while it is still wet.\u003c\/p\u003e\n\u003cp\u003eDuring the first 24 hours after application, children should not have prolonged and close contact with the treated animal, such as sleeping next to it.\u003c\/p\u003e\n\u003cp\u003eDo not smoke, eat or drink while handling this veterinary medicinal product.\u003c\/p\u003e\n\u003cp\u003eWash hands after handling the veterinary medicinal product.\u003c\/p\u003e\n\u003ch3\u003eOther precautions\u003c\/h3\u003e\n\u003cp\u003eThe solvent contained in this veterinary medicinal product may stain leather, fabrics, plastics and other surfaces. Allow the application site to dry before permitting contact with such materials or surfaces.\u003c\/p\u003e\n\u003cp\u003eEchinococcosis represents a hazard to humans. As echinococcosis is a notifiable disease to the World Organisation for Animal Health (WOAH), specific guidance on treatment, follow-up and human safety should be obtained from the relevant competent authorities.\u003c\/p\u003e\n\u003ch3\u003ePregnancy and lactation\u003c\/h3\u003e\n\u003cp\u003eMay be used during pregnancy and lactation.\u003c\/p\u003e\n\u003ch3\u003eInteraction with other medicinal products and other forms of interaction\u003c\/h3\u003e\n\u003cp\u003eEmodepside is a substrate for P-glycoprotein.\u003c\/p\u003e\n\u003cp\u003eConcurrent treatment with other substances that are substrates or inhibitors of P-glycoprotein, such as ivermectin and other antiparasitic macrocyclic lactones, erythromycin, prednisolone and ciclosporin, may increase the possibility of pharmacokinetic interactions.\u003c\/p\u003e\n\u003cp\u003eThe possible clinical consequences of such interactions have not been investigated.\u003c\/p\u003e\n\u003cp\u003eWhen your cat is receiving any other medicinal products, contact your veterinarian to discuss this before using this veterinary medicinal product.\u003c\/p\u003e\n\u003cp\u003eYou should also inform your veterinarian that this veterinary medicinal product is being used if the veterinarian administers any other medicinal product to your cat.\u003c\/p\u003e\n\u003ch3\u003eOverdose\u003c\/h3\u003e\n\u003cp\u003eSalivation, vomiting and neurological signs such as tremors were occasionally observed when this veterinary medicinal product was administered at ten times the recommended dose to adult cats and five times the recommended dose to kittens.\u003c\/p\u003e\n\u003cp\u003eThese signs may have been caused by the animal licking the application site after treatment. The signs were completely reversible.\u003c\/p\u003e\n\u003cp\u003eThere is no known specific antidote.\u003c\/p\u003e\n\u003ch3\u003eMajor incompatibilities\u003c\/h3\u003e\n\u003cp\u003eNone known.\u003c\/p\u003e\n\u003ch2\u003e7. Adverse events\u003c\/h2\u003e\n\u003ch3\u003eCats\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eVery rare — fewer than 1 animal in 10,000 animals treated, including isolated reports:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eTransient alopecia at the application site;\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003etransient itching at the application site;\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003etransient inflammation at the application site;\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003esalivation;\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003evomiting;\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003ediarrhoea;\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eloss of appetite;\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003emild and transient neurological disorders;\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003ebehavioural disorders.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSalivation, vomiting, diarrhoea and certain neurological signs may occur as a result of licking the application site immediately after treatment.\u003c\/p\u003e\n\u003cp\u003eNeurological disorders may include ataxia or tremors.\u003c\/p\u003e\n\u003cp\u003eBehavioural disorders may include hyperactivity, anxiety and increased vocalisation.\u003c\/p\u003e\n\u003cp\u003eReporting adverse events is important. It allows continuous monitoring of the safety of a veterinary medicinal product.\u003c\/p\u003e\n\u003cp\u003eWhen you notice any adverse events, including those not listed in this package leaflet, or you believe that the veterinary medicinal product has not worked, please inform your veterinarian.\u003c\/p\u003e\n\u003cp\u003eYou may also report adverse events directly to the marketing authorisation holder or its local representative using the contact details provided at the end of this package leaflet, or through the national reporting system on the website of the Food and Veterinary Service: \u003ca href=\"http:\/\/www.pvd.gov.lv\/\"\u003ewww.pvd.gov.lv\u003c\/a\u003e.\u003c\/p\u003e\n\u003ch2\u003e8. Dosage for each species, routes and method of administration\u003c\/h2\u003e\n\u003cp\u003eFor spot-on use.\u003c\/p\u003e\n\u003cp\u003eTo ensure administration of the correct dose, the animal’s body weight should be determined as accurately as possible.\u003c\/p\u003e\n\u003cp\u003eUnderdosing may result in ineffective treatment and may promote the development of resistance.\u003c\/p\u003e\n\u003ch3\u003eDosage and treatment schedule\u003c\/h3\u003e\n\u003cp\u003eThe recommended minimum doses are:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e12 mg praziquantel per kg of body weight;\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e3 mg emodepside per kg of body weight.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis corresponds to 0.14 ml of the veterinary medicinal product per kg of body weight.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eCat’s body weight\u003c\/th\u003e\n\u003cth align=\"right\"\u003ePipette size\/volume\u003c\/th\u003e\n\u003cth align=\"right\"\u003ePraziquantel\u003c\/th\u003e\n\u003cth align=\"right\"\u003eEmodepside\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e≥ 0.5–2.5 kg\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e0.35 ml\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e12–60 mg\/kg body weight\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e3–15 mg\/kg body weight\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u0026gt; 2.5–5 kg\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e0.70 ml\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e12–24 mg\/kg body weight\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e3–6 mg\/kg body weight\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u0026gt; 5–8 kg\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e1.12 ml\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e12–19.2 mg\/kg body weight\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e3–4.8 mg\/kg body weight\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMore than 8 kg\u003c\/td\u003e\n\u003ctd align=\"right\"\u003eUse an appropriate combination of pipettes intended for different weight ranges to ensure the correct dose.\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eA single treatment is effective for the treatment of roundworm and tapeworm infestations.\u003c\/p\u003e\n\u003cp\u003eFor the treatment of pregnant queens to prevent transmission of \u003cem\u003eToxocara cati\u003c\/em\u003e L3 larvae to their offspring through milk, a single treatment approximately seven days before the expected date of birth is effective.\u003c\/p\u003e\n\u003ch2\u003e9. Advice on correct administration\u003c\/h2\u003e\n\u003cp\u003eFor external use only.\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cp\u003eRemove the pipette from the package. Hold the pipette upright, twist and remove the cap.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eTurn the cap over and place the opposite end back onto the pipette. Press and twist the cap to break the seal, and then remove the cap from the pipette.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003ePart the animal’s coat at the base of the neck, in front of the shoulder blades, until the skin is visible. Place the tip of the pipette directly against the skin and squeeze it several times until the entire contents of the pipette have been applied directly to the skin.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eAvoid contact between the veterinary medicinal product and your fingers.\u003c\/p\u003e\n\u003cp\u003eApplication at the withers reduces the possibility of the animal licking off the veterinary medicinal product.\u003c\/p\u003e\n\u003ch2\u003e10. Withdrawal period\u003c\/h2\u003e\n\u003cp\u003eNot applicable.\u003c\/p\u003e\n\u003ch2\u003e11. Special storage precautions\u003c\/h2\u003e\n\u003cp\u003eKeep out of the sight and reach of children.\u003c\/p\u003e\n\u003cp\u003eStore in the original package in order to protect from light and moisture.\u003c\/p\u003e\n\u003cp\u003eThis veterinary medicinal product does not require any special temperature storage conditions.\u003c\/p\u003e\n\u003cp\u003eDo not use this veterinary medicinal product after the expiry date stated on the label and carton after “Exp.”\u003c\/p\u003e\n\u003cp\u003eThe expiry date refers to the last day of the stated month.\u003c\/p\u003e\n\u003ch2\u003e12. Special precautions for disposal\u003c\/h2\u003e\n\u003cp\u003eMedicines should not be disposed of via wastewater or household waste.\u003c\/p\u003e\n\u003cp\u003eThis veterinary medicinal product must not enter watercourses, as emodepside may be dangerous to fish and other aquatic organisms.\u003c\/p\u003e\n\u003cp\u003eUse take-back schemes for the disposal of any unused veterinary medicinal product or waste materials derived from it, in accordance with national requirements and any applicable national collection systems.\u003c\/p\u003e\n\u003cp\u003eThese measures help protect the environment.\u003c\/p\u003e\n\u003cp\u003eAsk your veterinarian or pharmacist how to dispose of veterinary medicinal products that are no longer required.\u003c\/p\u003e\n\u003cdiv\u003e\n\u003cp\u003e\u003cstrong\u003eStill have any questions?\u003c\/strong\u003e\u003cspan class=\"apple-converted-space\"\u003e\u003cstrong\u003e \u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cp\u003e\u003cspan style=\"color: #2b00ff;\"\u003e\u003cstrong\u003e\u003ca style=\"color: #2b00ff;\" href=\"https:\/\/zuzu.land\/pages\/services\" rel=\"noopener\" target=\"_blank\"\u003eSign up\u003c\/a\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003cspan class=\"apple-converted-space\"\u003e\u003cstrong\u003e \u003c\/strong\u003e\u003c\/span\u003e\u003cstrong\u003efor an online consultation with our licensed veterinary specialists. Online consults are a supplement to clinic visits - we don’t prescribe or diagnose.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cp\u003e\u003cspan style=\"color: #2b00ff;\"\u003e\u003cstrong\u003e\u003ca style=\"color: #2b00ff;\" title=\"Online veterinary services\" href=\"https:\/\/zuzu.land\/pages\/services\" rel=\"noopener\" target=\"_blank\"\u003eOnline Vet Help Is Just a Click Away!\u003c\/a\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"KRKA","offers":[{"title":"Default Title","offer_id":58646392406341,"sku":null,"price":11.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0552\/4327\/6372\/files\/193322.jpg?v=1784715810","url":"https:\/\/zuzu.land\/products\/krka-dehispot-30-mg-7-5-mg-0-35ml-for-cats-0-5-2-5kg-n1","provider":"ZuZu.land","version":"1.0","type":"link"}